Jacques Bernier
Editor

2011

Multimodality Management

For the last two decades, the management of the head and neck cancers has been characterized by a number of profound mutations, both triggered by the willingness of oncologists to reshape significantly their conceptual approaches to locally advanced diseases and facilitated by the advent of new, more active drugs.